Miguel A. Martínez González

• Birth: September 11, 1957
• Medical Doctor, University of Granada 1980
• PhD, University of Granada, 1993
• Chair, Department of Preventive Medicine and Public Health, University of Navarra, Pamplona, Spain
• Adjunct Professor Harvard TH Chan School of Public Health, Boston, USA
(https://www.hsph.harvard.edu/miguel-martinez-gonzalez/)
• Principal Investigator, CIBER-OBN, Nutritional Epidemiology group
• PI, SUN cohort, 23.000 participants (http://medpreventiva.es/xZd6Hh).
• Coordinator, PREDIMED Research Network (www.predimed.es)
• Principal Investigator, PREDIMED-Plus (http://medpreventiva.es/N37jk1)
• > 800 published research papers, (http://medpreventiva.es/s4o8M3)
• h-index=127 google, times cited > 60,000, (goo.gl/P5B0ml).

Prof Martínez-González is a medical epidemiologist of chronic disease with 30 years of experience.
He is a worldwide expert in the Mediterranean diet as a preventive approach for diabetes, cardiovascular disease, obesity and other chronic diseases.
He is the Principal Investigator (PI) of the SUN project (prospective dynamic cohort study investigating Mediterranean diet and chronic disease with around 23,000 participants and mean follow-up >10 years)
Prof. Martínez-González was the Coordinator of the PREDIMED Research Network funded by the Spanish NIH (2006-2013). PREDIMED conducted the largest randomized primary cardiovascular prevention trial with nutrition in Europe including 7447 participants in a Mediterranean dietary intervention.
Prof. Martínez-González was the PI of the European Research Council Advanced Research Grant to fund the PREDIMEDPLUS trial (http://cordis.europa.eu/project/rcn/188509_en.html), an on-going trial with 6,874 participants assessing the effects of an energy restricted Mediterranean diet with physical activity and weight loss on cardiovascular disease and type 2 diabetes.
Both the PREDIMED-1 trial (11 recruitment centres) and the PREDIMED-Plus multicentre trial (23 centres) commenced in Prof. Martínez-González’s centre (vanguard centre), which informed the design of the other centres.
He has been Co-PI of several NIH-funded grants on metabolomics, type 2 diabetes and cardiovascular disease (http://medpreventiva.es/HUqpLE)